Skip to content

Managing Psychological Distress Through Mindfulness-based CBT to Evaluate Its Effectiveness on Self-compassion Among Psoriasis Patients:The Mediating Role of Mental Health Locus of Control

Managing Psychological Distress Through Mindfulness-based CBT to Evaluate Its Effectiveness on Self-compassion Among Psoriasis Patients:The Mediating Role of Mental Health Locus of Control

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07615257
Acronym
managing psych
Enrollment
128
Registered
2026-05-29
Start date
2025-02-05
Completion date
2026-12-12
Last updated
2026-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis

Brief summary

Your research study is about evaluating the effectiveness of \*\*Mindfulness-Based Cognitive Therapy (MBCT)\*\* in reducing psychological distress among psoriasis patients and improving their self-compassion and Mental Health Locus of Control (MHLC). The study highlights that psoriasis patients often suffer not only from physical symptoms but also from psychological problems such as stress, anxiety, depression, self-judgment, and low self-compassion. Traditional treatments mainly focus on physical symptoms and may not fully address these emotional and psychological difficulties. To address this gap, the study proposes MBCT as a psychological intervention that combines mindfulness practices with cognitive therapy techniques. MBCT helps patients become more self-aware, reduce negative thinking, and develop self-compassion without self-judgment. The research also explores MHLC, which refers to how much control individuals believe they have over their health outcomes. The study aims to investigate whether MBCT can: * Reduce psychological distress, anxiety, depression, and stress levels * Improve self-compassion among psoriasis patients * Shift patients' locus of control from external to internal * Enhance emotional well-being and coping mechanisms The research follows a quantitative experimental design conducted in phases. Initially, baseline levels of distress, MHLC, and self-compassion will be assessed. Later, MBCT interventions will be implemented and evaluated for effectiveness. Overall, the study seeks to contribute to integrated psoriasis care by emphasizing the importance of psychological health alongside physical treatment, ultimately improving patients' quality of life and therapeutic outcomes.

Interventions

BEHAVIORALMindfulness-Based Cognitive Therapy (MBCT)

Mindfulness-Based Cognitive Therapy (MBCT) will be administered to psoriasis patients to reduce psychological distress and improve self-compassion and mental health locus of control. The intervention includes mindfulness practices and cognitive behavioral techniques delivered in structured sessions.

OTHERUsual Care

Participants in the control group will receive usual care without Mindfulness-Based Cognitive Therapy intervention.

Sponsors

Islamia University of Bahawalpur
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
25 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed psoriasis patients * Age between 18 and 65 years * Both male and female participants * Participants willing to provide informed consent * Participants experiencing psychological distress

Exclusion criteria

* Under the age of 18 years will be excluded. * Patients with severe psychiatric disorders * Patients currently receiving other psychological therapies * Patients with serious medical or neurological conditions * Participants unwilling to continue the intervention sessions * Patients with cognitive impairment affecting participation

Design outcomes

Primary

MeasureTime frameDescription
Reduction in Psychological Distress12 weeksTo evaluate the effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) in reducing psychological distress among psoriasis patients.

Countries

Pakistan

Contacts

CONTACTRafia Ghaffar, Phd
rafiaghaffar1@gmail.com923336096376

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 30, 2026